Cancer News and Research

Latest Cancer News and Research

The risk of adverse reactions when herbal medications are taken with cancer drugs

A new study discusses phytovigilance initiatives based on the real-world use of herbal drugs in cancer along with conventional chemotherapy.

24 Aug 2022

Soft-tissue sarcomas produce a protein that make immune cells 'go bad'

Investigators from Cedars-Sinai Cancer have discovered that cancerous tumors called soft-tissue sarcomas produce a protein that switches immune cells from tumor-attacking to tumor-promoting.

24 Aug 2022

Researchers discover a new class of more potent and less toxic drugs for leukemia patients

Chemotherapy sucks. The treatments generally have awful side effects, and it's no secret that the drugs involved are often toxic to the patient as well as their cancer.

24 Aug 2022

Using the power of CRISPR to engineer better, stronger, longer-lived T cells

T cells used in immunotherapy treatments can get exhausted by the task of fighting cancer cells or get shutdown as they enter tumors.

24 Aug 2022

Study compares psychedelic experiences with near-death experiences

In a survey study of more than 3,000 adults, Johns Hopkins Medicine researchers compared psychedelic experiences with near-death experiences that were not drug related and found notable similarities in people's attitudes toward death.

24 Aug 2022

Study suggests no lasting setback for urologists in training after COVID-19 pandemic

After the onset of the COVID-19 pandemic, urology training programs saw a precipitous drop in opportunities for residents to gain hands-on surgical experience, reports a study in Urology Practice, an Official Journal of the American Urological Association. The journal is published in the Lippincott portfolio by Wolters Kluwer.

24 Aug 2022

CRISPR genome-editing technology can be used as a tool to discover RNA therapeutics for lung cancer

An international team of scientists have demonstrated for the first time that CRISPR genome-editing technology can be used as a tool to find new gene therapies for lung cancer.

24 Aug 2022

Social media messaging strategies can help educate young adults about HPV vaccine interventions

Public health researchers from the University of California, Irvine identified several social media messaging strategies to educate young adults and their parents about evidence-based interventions around the human papillomaviruses (HPV).

24 Aug 2022

Many leisure time activities associated with lower risk of death from cardiovascular disease, cancer

Older adults who participate weekly in many different types of leisure time activities, such as walking for exercise, jogging, swimming laps, or playing tennis, may have a lower risk of death from any cause, as well as death from cardiovascular disease and cancer, according to a new study led by researchers at the National Cancer Institute, part of the National Institutes of Health.

24 Aug 2022

Researchers discover the vital role of immune cells in liver regeneration

If liver tissue has to be removed due to cancer or another liver disease, the organ usually regenerates quickly, soon becoming fully functional once again.

24 Aug 2022

Researchers identify a potential new therapeutic approach to fight angioimmunoblastic T-cell lymphoma

A type of blood cell cancer called angioimmunoblastic T-cell lymphoma (AITL) can develop as mutations accumulate with age in the stem cells from which the T cells in the blood develop.

24 Aug 2022

Ian Frazer Centre for Children’s Immunotherapy Research aims to advance pediatric cancer care

Australia's first dedicated children's immunotherapy center will investigate treatments to not only increase the survival of kids with cancer, but to also improve their ongoing quality of life.

24 Aug 2022

Transposable element expression changes in response to SARS-CoV-2 infection

Researchers observed that transposable element activation is impaired during infection with SARS-CoV-2.

24 Aug 2022

Study shows 44% of global cancer deaths are preventable

A recent study estimates the global cancer burden triggered by behavioral, environmental, occupational, and metabolic risk factors.

24 Aug 2022

Unconventional T cells influence immune responses in the lymph nodes

Lymph nodes trigger very different immune responses – depending on which body tissue they are connected to. Special T cells are responsible for this newly discovered relation.

23 Aug 2022

UCI study uncovers key insights into 'parasitic genes'

They are considered "parasitic genes." Even though they comprise over half of human DNA, much remains to be learned about them.

23 Aug 2022

Wyss Institute's DNA nanotechnology-driven SPEAR protein-detection technology licensed to Spear Bio

Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc.announced that the Institute's DNA nanotechnology-driven ultrasensitive SPEAR protein-detection technology has been licensed to the newly formed Boston-based startup.

23 Aug 2022

Common molecular tool for DNA labelling shows unexpected anticancer properties

Scientists at the UNC School of Medicine have made the surprising discovery that a molecule called EdU, which is commonly used in laboratory experiments to label DNA, is in fact recognized by human cells as DNA damage, triggering a runaway process of DNA repair that is eventually fatal to affected cells, including cancer cells.

23 Aug 2022

Researchers assess the cytoprotective activity of nicotine against COVID-19

In a newly released study, researchers assessed the cytoprotective activity of nicotine against COVID-19.

23 Aug 2022

Unconventional oil and gas development exposure increases the risk for acute lymphoblastic leukemia in children

A new study assessed the associations between residential proximity to unconventional oil and gas development and acute lymphoblastic leukemia risk.

23 Aug 2022

Cancer News and Research

Latest Cancer News and Research

The risk of adverse reactions when herbal medications are taken with cancer drugs

Soft-tissue sarcomas produce a protein that make immune cells 'go bad'

Researchers discover a new class of more potent and less toxic drugs for leukemia patients

Using the power of CRISPR to engineer better, stronger, longer-lived T cells

Study compares psychedelic experiences with near-death experiences

Study suggests no lasting setback for urologists in training after COVID-19 pandemic

CRISPR genome-editing technology can be used as a tool to discover RNA therapeutics for lung cancer

Social media messaging strategies can help educate young adults about HPV vaccine interventions

Many leisure time activities associated with lower risk of death from cardiovascular disease, cancer

Researchers discover the vital role of immune cells in liver regeneration

Researchers identify a potential new therapeutic approach to fight angioimmunoblastic T-cell lymphoma

Ian Frazer Centre for Children’s Immunotherapy Research aims to advance pediatric cancer care

Transposable element expression changes in response to SARS-CoV-2 infection

Study shows 44% of global cancer deaths are preventable

Unconventional T cells influence immune responses in the lymph nodes

UCI study uncovers key insights into 'parasitic genes'

Wyss Institute's DNA nanotechnology-driven SPEAR protein-detection technology licensed to Spear Bio

Common molecular tool for DNA labelling shows unexpected anticancer properties

Researchers assess the cytoprotective activity of nicotine against COVID-19

Unconventional oil and gas development exposure increases the risk for acute lymphoblastic leukemia in children

Industry Focus: Cell & Gene Therapy eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Cancer News and Research

Latest Cancer News and Research

Industry Focus: Cell & Gene Therapy eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in